Stay updated on PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial

Sign up to get notified when there's something new on the PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A new revision entry is added to the Record History: Revision: v3.3.4. This is a routine site revision update and does not modify trial data or study details.
    Difference
    0.1%
    Check dated 2026-01-14T04:12:01.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Record History now lists the latest known status and sponsor (Jiangsu HengRui Medicine Co., Ltd.) with a 2022-10 date, and includes Recruitment Status and Study Status details as of 2022-11-16.
    Difference
    0.9%
    Check dated 2026-01-07T02:06:17.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    A new revision label (Revision: v3.3.3) was added to the History. The HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed from the footer.
    Difference
    0.2%
    Check dated 2025-12-23T21:32:27.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The Record History now includes a new revision entry v3.3.2 and removes v3.2.0 from the list. This updates the visible revision history and reflects the latest changes to the trial record.
    Difference
    0.1%
    Check dated 2025-11-25T10:17:30.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The government funding notice/banner at the top of the page has been removed, and the trial record content and navigation remain unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2025-11-18T06:48:05.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Version history shows updates to Study Status and Recruitment Status, including changes to Contacts/Locations. These updates reflect changes in the trial's current activity and site information.
    Difference
    0.1%
    Check dated 2025-11-03T20:42:02.000Z thumbnail image

Stay in the know with updates to PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial page.